Press releasesKeep up with the latest news from Ikena Oncology.August 18, 2020 Ikena Oncology Appoints Dr. Sergio Santillana, MD, MSc, MBA as Chief Medical OfficerAugust 12, 2020 Ikena Oncology Announces Publication in Nature Communications of Preclinical Data Supporting the Therapeutic Potential of AHR BlockadeJune 22, 2020 Ikena Oncology Presents New Preclinical Data Highlighting the Anti-Cancer Effects of TEAD Inhibition on the Hippo Signaling PathwayJanuary 28, 2020 Ikena Oncology Announces Dosing of First Patient in Phase 1 Study Evaluating IK-175 in Patients with Advanced Solid TumorsDecember 3, 2019 Kyn Therapeutics Rebrands as Ikena Oncology, Reflecting Next Phase of GrowthMay 7, 2019 Kyn Therapeutics Strengthens Leadership Team with Key AppointmentsFebruary 4, 2019 Kyn Therapeutics Appoints Douglas Carlson as Chief Financial OfficerJanuary 18, 2019 Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene to Develop Immuno-oncology Therapies 12>>Access our media kit page to view and download assorted corporate assets.View Media Kit
